Difficulty: Medium
Average Score: 86%
Practice
A client with chronic renal disease is receiving therapy with epoetin alfa. Which of the following laboratory results should the nurse review for an indication of a therapeutic effect of the medication?
Correct answer
C
Rationale
In this scenario, the correct laboratory result to review for an indication of a therapeutic effect of epoetin alfa in a client with chronic renal disease is the hematocrit (Hct). Epoetin alfa is a medication that stimulates red blood cell production, and an increase in the hematocrit level indicates a positive response to the treatment.
Option A, the leukocyte count, is not relevant in this context as it measures white blood cells, which are not directly affected by epoetin alfa therapy. Option B, the platelet count, is also unrelated to the medication's therapeutic effect on red blood cell production.
Option D, the erythrocyte sedimentation rate (ESR), is a nonspecific indicator of inflammation and not specifically related to the action of epoetin alfa in stimulating erythropoiesis.
Understanding the rationale behind monitoring specific laboratory values in response to pharmacological interventions is crucial in nursing practice. By recognizing the significance of changes in hematocrit levels with epoetin alfa therapy, nurses can effectively evaluate the medication's efficacy and adjust treatment as needed to optimize patient outcomes in clients with chronic renal disease.
Option A, the leukocyte count, is not relevant in this context as it measures white blood cells, which are not directly affected by epoetin alfa therapy. Option B, the platelet count, is also unrelated to the medication's therapeutic effect on red blood cell production.
Option D, the erythrocyte sedimentation rate (ESR), is a nonspecific indicator of inflammation and not specifically related to the action of epoetin alfa in stimulating erythropoiesis.
Understanding the rationale behind monitoring specific laboratory values in response to pharmacological interventions is crucial in nursing practice. By recognizing the significance of changes in hematocrit levels with epoetin alfa therapy, nurses can effectively evaluate the medication's efficacy and adjust treatment as needed to optimize patient outcomes in clients with chronic renal disease.